STING1 and neoplasm: Intratumoral microbiota, activate the STING signaling pathway, stimulating immune responses, including T cells, and NK cells, fostering tertiary lymphoid structures (TLS), and enhancing anti-tumor immunity through specific antigen presentation.[54,55]